Simon ellison

MD Anderson emerges with strong evidence for natural killer cell therapy, and Takeda looks like a winner lnkd.in/eJyRXC6

Unlawful Stem Cell Products Continue to Harm People as FDA Deadline Looms lnkd.in/eUN9pww

Mesoblast Submits Completed Biologics License Application for Ryonciltm to US FDA lnkd.in/ekDn9M9

Catalent To Acquire Leading Cell Therapy Company MaSTherCell Global for $315M, Creating an Industry-Leading Cell & Gene Therapy Platform lnkd.in/e2NDYDE

Beam Therapeutics Announces Pricing of $180M Initial Public Offering lnkd.in/eNmyMFT

Sonoma Biotherapeutics Launches With $40M in Series A Funding to Advance Regulatory T Cell Therapy in Autoimmune and Degenerative Diseases lnkd.in/eJDeYkZ

Catalent Buys Cell Therapy Company MaSTherCell Global, For $315M lnkd.in/eYpxyiU

Congratulation Matthew lnkd.in/eascFur

With the emergence of #cellandgenetherapy, manufacturers need partners with the expertise to develop the right plan to meet their immediate needs and help them scale smoothly. @Simon_H_Ellison shares his insight with @FiercePharma #advancedtherapies

Iovance and Cellectis Working together lnkd.in/e-P4jR2

Friday, Jan. 10 is the last day to register for this free in-person event or webinar on #SupplyChain and #logistics in #CGT featuring @Simon_H_Ellison Jacqueline Barry, Greg Crescenzi, Anuj Singla, Donna Wall and @MichaelMay5 Register now bit.ly/34oUbC7 @CellCAN_Network

"The UK’s Cell and Gene Therapy Catapult has played a significant role in building the strong #advancedtherapy ecosystem in the UK – the largest outside the USA". Keith Thompson, CEO talks to @medicine_maker in this week's #manufacturing feature: themedicinemaker.com/manufacture/a-…

Novartis' AveXis opens Zolgensma plant in Colorado with 350 employees lnkd.in/eK6FszM

Quite the exposé about dodgy stem cell clinics on Radio 4 last night bbc.in/2Frwcrn cc @cells_nnm

The Advanced Therapy Treatment Centre (ATTC) network was set up 18 months ago in response to the challenge faced by the UK to bring cell and gene therapies into routine medical practice. See the impact of the ATTC Network after 18 months of operation👇

After 18 months of operation, the ATTC network continues to work with industry partners & the public sector across the UK to develop necessary processes & infrastructure at scale as more #innovative products move from #clinicaltrial to market. Learn more: ow.ly/Y1ni50xPhA2

With 98% of #advancedtherapy companies looking to increase their headcount in the next five years, there is accelerated demand for specialist skills in the UK #celltherapy & #genetherapy industry. Skills Demand report findings covered by @BioPharmaReport biopharma-reporter.com/Article/2020/0…

To meet market demand we now have storage capability in Istanbul lnkd.in/eF3JVdN

China convicts 3 researchers involved in gene-edited babies lnkd.in/egHGNc6

Japanese pharma company Astellas has inked a deal to buy out US-based biotech Xyphos, to bolster its immuno-oncology pipeline. lnkd.in/eFf4Kix